Brochure
26 Aug 2026
Pharmaceutical Solutions
PDF 3.8 MB
Discover Grace’s comprehensive pharmaceutical solutions portfolio, including our North American CDMO capabilities for small molecule development and manufacturing, and custom engineered silica products.
Content provided by our supplier
Grace GmbH
-
Country/Region:Germany
-
On CPHI since:2022
-
Employees:1000 - 4999
Company types
Primary activities
Other Content from Grace GmbH (6)
-
Brochure Grace’s Fine Chemical Manufacturing Services (FCMS)
Grace FCMS is a U.S.-based CDMO supporting small molecule APIs, RSMs, and peptide building blocks from development to commercial production. -
Brochure SYLOID® FP Silica: Multifunctional Excipients
SYLOID® FP silica combines adsorption, particle size, density, and surface area to reduce excipients, simplify formulations, and improve efficiency. -
Brochure From IND to NDA: The Role of the Kilo Lab in a Seamless Scaleup
Explore the role of kilo labs in small molecule development and how Grace’s scale-up approach helps improve manufacturing readiness. -
Whitepaper Enhance Peptide Innovation With A High-Quality Supply Of Building Blocks
This article explores how complex peptide building blocks can help improve peptide therapeutics by extending half-life, increasing potency, and enhancing patient convenience. Partnering early with an experienced, compliant manufacturing provider can help ensure a reliable supply of high-quality peptide building blocks while addressing complex development, analytical, and regulatory requirements. -
Brochure VYVID™ Superparamagnetic Silicas
Discover Grace's range of magnetic separation technology for in-vitro diagnostics. VYVID™ Superparamagnetic silica beads are ideal for rapid isolation and purification of nucleic acids, eliminating the need for columns and centrifugations.
-
Whitepaper Leveraging Machine Learning to Accelerate Drug Development
Download this whitepaper that explores how CDMOs can apply machine learning to help get innovative treatments to patients quicker.